Y-mAbs Therapeutics Inc (YMAB)
13.62
-3.62
(-20.97%)
USD |
NASDAQ |
May 08, 16:00
13.62
0.00 (0.00%)
After-Hours: 18:51
Y-mAbs Therapeutics 1 Year Total Returns (Daily): 149.5% for May 7, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 07, 2024 | 149.5% |
| May 06, 2024 | 149.5% |
| May 03, 2024 | 179.3% |
| May 02, 2024 | 192.9% |
| May 01, 2024 | 167.3% |
| April 30, 2024 | 153.9% |
| April 29, 2024 | 158.8% |
| April 26, 2024 | 158.5% |
| April 25, 2024 | 156.7% |
| April 24, 2024 | 158.7% |
| April 23, 2024 | 160.9% |
| April 22, 2024 | 157.8% |
| April 19, 2024 | 161.3% |
| April 18, 2024 | 134.7% |
| April 17, 2024 | 127.6% |
| April 16, 2024 | 131.5% |
| April 15, 2024 | 128.0% |
| April 12, 2024 | 130.7% |
| April 11, 2024 | 138.7% |
| April 10, 2024 | 127.9% |
| April 09, 2024 | 145.5% |
| April 08, 2024 | 152.2% |
| April 05, 2024 | 143.4% |
| April 04, 2024 | 153.2% |
| April 03, 2024 | 153.0% |
| Date | Value |
|---|---|
| April 02, 2024 | 194.6% |
| April 01, 2024 | 223.2% |
| March 28, 2024 | 422.8% |
| March 27, 2024 | 444.6% |
| March 26, 2024 | 416.4% |
| March 25, 2024 | 416.8% |
| March 22, 2024 | 473.5% |
| March 21, 2024 | 466.6% |
| March 20, 2024 | 396.5% |
| March 19, 2024 | 363.9% |
| March 18, 2024 | 328.7% |
| March 15, 2024 | 336.2% |
| March 14, 2024 | 345.1% |
| March 13, 2024 | 363.2% |
| March 12, 2024 | 399.7% |
| March 11, 2024 | 412.1% |
| March 08, 2024 | 358.9% |
| March 07, 2024 | 339.9% |
| March 06, 2024 | 343.1% |
| March 05, 2024 | 308.3% |
| March 04, 2024 | 325.3% |
| March 01, 2024 | 368.4% |
| February 29, 2024 | 339.5% |
| February 28, 2024 | 329.7% |
| February 27, 2024 | 341.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.17%
Minimum
Nov 03 2022
473.5%
Maximum
Mar 22 2024
6.07%
Average
-17.85%
Median
May 12 2021
1 Year Total Returns (Daily) Benchmarks
| The Cooper Companies Inc | -3.17% |
| Puma Biotechnology Inc | 50.63% |
| Humacyte Inc | 0.11% |
| Moderna Inc | -11.67% |
| NovaBay Pharmaceuticals Inc | -91.08% |